Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.
BackgroundPulmonary arterial hypertension (PAH) is a progressive chronic disease with poor outcomes.One reason for poor prognosis is the lack of understanding regarding individual variability in response to treatment.Idiopathic PAH (IPAH) patients with bone morphogenetic protein receptor type Conditioner 2 (BMPR2) mutations have distinct phenotypes